27 States Sue 23andMe Over Sale of Customer DNA Data Without Consent

---

Full Story

Twenty-seven states and the District of Columbia filed a lawsuit against 23andMe on Tuesday, opposing the sale of customer DNA data without direct consent. The suit claims this data is a highly sensitive and unique compilation of personal information. The case highlights growing concerns about privacy in genetic testing.

The lawsuit was announced on Tuesday. It targets 23andMe’s data-sharing practices.

MEDIA REPORTING

See how news sources on all sides are covering this story.

Left 31% | Right 25% | Center 38% | Unrated 6%

The Context

DNA data is considered highly personal. Its sale raises ethical and legal questions.

23andMe provides consumer genetic testing services. Customers submit samples for ancestry or health risks.

The suit claims customers weren’t properly informed consent is critical. Consent is central to privacy laws.

States argue the data is immutable. Unauthorized sales could lead to misuse.

Genetic privacy has become a national issue. Other companies face similar legal challenges.

Some support corporate data use for research. Others demand stricter privacy protections.